Bath & Body Works stock plunges as retailer misses third-quarter earnings, announces turnaround plan

Bath & Body Works shares plunged nearly 25% to a 52-week low after the company reported disappointing Q3 results and cut its full-year outlook amid “macro consumer pressures,” sending the stock more than 50% lower year-to-date. The company missed LSEG analyst estimates with adjusted EPS of $0.35 versus $0.39 and revenue of $1.59 billion versus $1.63 billion, reporting net income of $77 million ( $0.37) down from $106 million a year earlier, and now expects Q4 revenue to decline in the high single digits versus a 1.5% growth consensus and full-year net sales to grow only in the low single digits. CEO Daniel Heaf unveiled a “Consumer First Formula” turnaround targeting $250 million in cost savings by 2027, refocusing on core body-care, fragrance and soap categories (exiting haircare and men’s grooming), plus influencer marketing, app/website upgrades and a lower free-shipping threshold to attract younger consumers — actions intended to restore growth but that leave near-term top-line risks amid weak consumer demand and tariff pressures.

Analysis

Bath & Body Works shares plunged nearly 25% to a 52-week low after the company reported disappointing third-quarter results and slashed its full-year outlook; the stock is down more than 50% year-to-date. The company reported adjusted EPS of $0.35 versus LSEG consensus $0.39 and revenue of $1.59 billion versus $1.63 billion, with GAAP net income of $77 million ($0.37) versus $106 million ($0.49) a year ago.

Management attributed the shortfall to “macro consumer pressures” and tariff impacts and now expects fourth-quarter revenue to decline in the high single digits versus Street estimates of a 1.5% increase, while full-year net sales were revised to grow only in the low single digits. That guidance implies near-term top-line deterioration and potential margin pressure as the company defends share amid weaker demand.

CEO Daniel Heaf unveiled a "Consumer First Formula" turnaround targeting $250 million in cost savings by 2027, a refocus on core body-care, fragrance and soap categories (exiting haircare and men's grooming), influencer-driven marketing, and digital upgrades including an app revamp and a lower free-shipping threshold in early 2026. The plan addresses relevance and cost structure but carries significant execution risk and a multi-year timeline; investors should watch quarterly updates on cost savings, younger-consumer traction, and any additional guidance revisions as primary re-rating catalysts.

Key Decisions for Investors

• Reduce or hedge near-term exposure until the company demonstrates stabilization in top-line trends or provides clearer Q4/2025 guidance given the high-single-digit Q4 decline and lowered full-year outlook
• Monitor execution milestones closely: quarterly progress toward the $250 million cost-savings target, evidence of digital/app engagement and influencer ROI, and any improvements in comparable sales before adding to positions
• Consider selective, staged accumulation only for investors with a multi-year horizon and tolerance for execution risk, and use position sizing or option protection to limit downside during the turnaround
• Track macro consumer-sentiment indicators and tariff developments cited by management as catalysts that could materially alter the recovery trajectory